Published in Trans R Soc Trop Med Hyg on October 26, 1998
Synergism between amodiaquine and its major metabolite, desethylamodiaquine, against Plasmodium falciparum in vitro. Antimicrob Agents Chemother (2004) 0.80
Efficacy of amodiaquine in uncomplicated falciparum malaria in Nigeria in an area with high-level resistance to chloroquine and sulphadoxine/pyrimethamine. Parasitol Res (2005) 0.78
Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet (1996) 4.13
Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance. Mol Biochem Parasitol (1998) 2.08
In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Am J Trop Med Hyg (1996) 1.55
Desipramine or cyproheptadine for reversing chloroquine resistance? Lancet (1990) 1.52
Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequence. Gene (1998) 1.37
In vitro antimalarial activity of limonoids from Khaya grandifoliola C.D.C. (Meliaceae). J Ethnopharmacol (2000) 1.37
Kinetic properties of dihydrofolate reductase from wild-type and mutant Plasmodium vivax expressed in Escherichia coli. Mol Biochem Parasitol (2001) 1.28
Comparison of in vivo and in vitro tests of resistance in patients treated with chloroquine in Yaoundé, Cameroon. Bull World Health Organ (1999) 1.21
In vitro activity of lumefantrine (benflumetol) against clinical isolates of Plasmodium falciparum in Yaoundé, Cameroon. Antimicrob Agents Chemother (1998) 1.20
Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in African children. Clin Infect Dis (1998) 1.12
In vitro activities of pyronaridine, alone and in combination with other antimalarial drugs, against Plasmodium falciparum. Antimicrob Agents Chemother (1999) 1.07
False chloroquine resistance in Africa. Lancet (1997) 1.06
Malaria and pregnancy in Cameroonian primigravidae: humoral and cellular immune responses to Plasmodium falciparum blood-stage antigens. Am J Trop Med Hyg (1995) 1.04
Plasmodium falciparum: detection of P-glycoprotein in chloroquine-susceptible and chloroquine-resistant clones and isolates. Exp Parasitol (1995) 1.02
Immune response to Plasmodium falciparum antigens in Cameroonian primigravidae: evolution after delivery and during second pregnancy. Clin Exp Immunol (1997) 1.00
Plasmodium falciparum: detection of antifolate resistance by mutation-specific restriction enzyme digestion. Exp Parasitol (1995) 1.00
In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Am J Trop Med Hyg (1999) 0.99
Malaria cellular immune responses in neonates from Cameroon. Parasite Immunol (1996) 0.99
In vitro culture and drug sensitivity assay of Plasmodium falciparum with nonserum substitute and acute-phase sera. J Clin Microbiol (1999) 0.99
[Malaria in health centres in the southern districts of Brazzaville, Congo]. Bull Soc Pathol Exot (2008) 0.97
Chemoresistance of P. falciparum in urban areas of Yaounde, Cameroon. Part 1: Surveillance of in vitro and in vivo resistance of Plasmodium falciparum to chloroquine from 1994 to 1999 in Yaounde, Cameroon. Trop Med Int Health (2000) 0.95
Chemoresistance of Plasmodium falciparum in the urban region of Yaounde, Cameroon. Part 2: Evaluation of the efficacy of amodiaquine and sulfadoxine-pyrimethamine combination in the treatment of uncomplicated Plasmodium falciparum malaria in Yaounde, Cameroon. Trop Med Int Health (2000) 0.95
Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients. Am J Trop Med Hyg (1994) 0.91
Detection of Plasmodium ovale malaria parasites by species-specific 18S rRNA gene amplification. Mol Cell Probes (1997) 0.90
Heterogeneity in the circumsporozoite protein gene of Plasmodium malariae isolates from sub-Saharan Africa. Mol Biochem Parasitol (1998) 0.90
Association between antifol resistance in vitro and DHFR gene point mutation in Plasmodium falciparum isolates. Trans R Soc Trop Med Hyg (1996) 0.90
Diagnosis of Plasmodium malariae infection by the polymerase chain reaction. Trans R Soc Trop Med Hyg (1997) 0.88
In-vitro activity of primaquine against the asexual blood stages of Plasmodium falciparum. Ann Trop Med Parasitol (1999) 0.88
In vitro activities of novel catecholate siderophores against Plasmodium falciparum. Antimicrob Agents Chemother (1996) 0.87
In vitro and in vivo potentiation of chloroquine against malaria parasites by an enantiomer of amlodipine. Antimicrob Agents Chemother (1991) 0.87
Evaluating the efficacy of chloroquine in febrile Guinean children infected with Plasmodium falciparum by a simplified in vivo test. Bull World Health Organ (1992) 0.87
Plasma concentrations of the enantiomers of halofantrine and its main metabolite in malaria patients. Eur J Clin Pharmacol (1994) 0.86
Short report: effects of pyronaridine on gametocytes in patients with acute uncomplicated falciparum malaria. Am J Trop Med Hyg (1999) 0.86
Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected African patients. Am J Trop Med Hyg (2001) 0.85
Assessment of three in vitro tests and an in vivo test for chloroquine resistance in Plasmodium falciparum clinical isolates. J Clin Microbiol (1998) 0.84
DHFR gene point mutation as a predictor of Plasmodium falciparum resistance to cycloguanil in malaria cases from Africa imported to France. Trans R Soc Trop Med Hyg (1997) 0.82
Pyronaridine for treatment of Plasmodium ovale and Plasmodium malariae infections. Antimicrob Agents Chemother (1997) 0.81
Halofantrine resistance in African countries. Lancet (1993) 0.80
Humoral and cellular immune responses to synthetic peptides from the Plasmodium falciparum blood-stage antigen, Pf155/RESA, in Cameroonian women. Clin Immunol Immunopathol (1995) 0.80
Evaluation of a new sulfadoxine sensitivity assay in vitro for field isolates of Plasmodium falciparum. Trans R Soc Trop Med Hyg (2001) 0.79
Plasmodium vivax: rapid detection by polymerase chain reaction and restriction fragment length polymorphism of the key mutation in dihydrofolate reductase-thymidylate synthase gene associated with pyrimethamine resistance. Exp Parasitol (1998) 0.78
Absence of effect of retinol on the in vitro development of Plasmodium falciparum. Int J Vitam Nutr Res (1992) 0.77
Uptake of mefloquine enantiomers into uninfected and malaria-infected erythrocytes. Drug Metab Dispos (1996) 0.77
Use of a semi-nested PCR diagnosis test to evaluate antifolate resistance of Plasmodium falciparum isolates. Mol Cell Probes (1995) 0.77
[In vivo evaluation of sulfadoxine-pyrimethamine efficacy during uncomplicated falciparum malaria in children of Yopougon (Abidjan, Côte d'Ivoire)]. Bull Soc Pathol Exot (2004) 0.77
In vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, quinine, mefloquine and halofantrine in Abidjan (Côte d'Ivoire). Afr Health Sci (2010) 0.76
Malarone-donation programme in Africa. Lancet (1998) 0.75
Confused malaria chemoprophylaxis. Lancet (1994) 0.75
Inefficacy of amodiaquine against chloroquine-resistant malaria. Lancet (1991) 0.75
Surveillance of antifolate-resistant malaria. Lancet (1998) 0.75
Antimalarial chemoprophylaxis for west Africa. Lancet (1993) 0.75
[Variability of in vitro activity of proguanil and cycloguanil on erythrocyte stages of Plasmodium falciparum as a function of culture conditions]. Bull Soc Pathol Exot (1999) 0.75
[Mefloquine and halofantrine, new therapeutic drugs of malaria]. Rev Med Interne (1991) 0.75
Analysis of Plasmodium falciparum multidrug-resistance (pfmdr1) gene mutation by hairpin-dependent cleavage fragment length polymorphism. Mol Biochem Parasitol (1997) 0.75
Efficacy and tolerance in adults of a short (3 days) course of quinine for uncomplicated falciparum malaria. Ann Soc Belg Med Trop (1995) 0.75
[Drug sensitivity of falciparum malaria imported into France in 1995]. Bull Soc Pathol Exot (1997) 0.75
[Mechanisms and epidemiology of resistances to antimalarials]. C R Seances Soc Biol Fil (1996) 0.75
Chloroquine and proguanil prophylaxis in travellers to Kenya. Lancet (1992) 0.75
[Contribution of molecular genetics to the understanding of chemoresistance of Plasmodium falciparum]. Bull Soc Pathol Exot (1992) 0.75